Fatty acid oxidation enzyme gene expression is downregulated in the failing heart

Circulation

Volumn 94, Issue 11, 1996, Pages 2837-2842

  Sack, Michael N ^a   Rader, Toni A ^a   Park, Sonhee ^b   Bastin, Jean ^c   McCune, Sylvia A ^b   Kelly, Daniel P ^a,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

fatty acids; heart failure; hypertrophy; metabolism

Indexed keywords

ADULT; AEROBIC METABOLISM; ARTICLE; CLINICAL ARTICLE; ENERGY BALANCE; ENZYME ACTIVITY; FATTY ACID OXIDATION; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE UTILIZATION; GLYCOLYSIS; HEART FAILURE; HEART VENTRICLE OVERLOAD; HUMAN; MALE; METABOLIC REGULATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM;

EID: 0029800177     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2837     Document Type: Article

References (42)

1. Bing RJ. The metabolism of the heart. Harvey Lect. 1955;50:27-70.
2. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Prob Cardiol. 1994;19:57-116.
3. Scheuer J. Metabolic factors in myocardial failure. Circulation. 1993;87(suppl VII):VII-54-VII-57.
4. Moalic J-M, Charlemagne D, Mansier P, Chevalier B, Swynghedauw B. Cardiac hypertrophy and failure: a disease of adaptation. Circulation. 1993;87(suppl IV):IV-21-IV-26.
5. Wittels B, Spann JF Jr. Defective lipid metabolism in the failing heart. J Clin Invest. 1968;47:1787-1794.
6. Bishop SP, Altschuld RA. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol. 1970;218:153-159.
7. Feinendegen LE, Henrich MM, Kuikka JT, Thompson KH, Vester EG, Strauer B. Myocardial lipid turnover in dilated cardiomyopathy: a dual in vivo tracer approach. J Nucl Cardiol. 1995;2:42-52.
8. Bremer J. Osmundsen H. Fatty acid oxidation and its regulation. In: Numa S, ed. Fatty Acid Metabolism and Its Regulation. Amsterdam, Netherlands: Elsevier Science Publishers BV; 1984:113-154.
9. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med. 1993;330:913-919.
10. McCune SA, Jenkins JE, Stills HF Jr, Park S, Radin MJ, Jurin RR, Hamlin RE. Renal and heart function in the SHHF/Mcc-cp rat. In: Shafrir E, ed. Frontiers in Diabetes Research: Lessons From Animal Diabetes III. London, UK: Smith-Gorden; 1991:397-401.
11. McCune SA, Park S, Radin MJ, Jurin RR. The SHHF/Mcc-facp: a genetic model of congestive heart failure. In: Singal PK, Dixon IMC, Beamish RE, Dhalla NS, eds. Mechanisms of Heart Failure. Boston, Mass: Kluwer Academic Publishers; 1995:91-106.
12. cp rats. FASEB J. 1996;10:A345. Abstract.
13. Kelly DP, Gordon JI, Alpers R, Strauss AW. The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins: medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J Biol Chem. 1989;264:18921-18925.
14. Cresci S, Wright LD, Spratt JA, Briggs FN, Kelly DP. Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle. Am J Physiol. 1996;270:C1413-C1420.
15. Hainline BE, Kahlenbeck DJ, Grant J, Strauss AW. Tissue specific and developmental expression of rat long- and medium-chain-acyl-CoA debydrogenases. Biochim Biophys Acta. 1993;1216:460-468.
16. Sims HF, Bracken JC, Powell CK, Treem WR, Hale DE, Bennett MJ, Gibson B, Shapiro S, Strauss AW. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci U S A. 1995;92:841-845.
17. Tso JY, Sun X-H, Kao T-H, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 1985;13:2485-2502.
18. Elliott TS, Swartz DA, Paisley EA, Mangian HJ, Visek WJ, Kaput J. F1Fo-ATPase subunit e gene isolated in a screen for diet regulated genes. Biochem Biophys Res Commun. 1993;190:167-174.
19. Sambrook J, Fritsch EF, Maniatis T. Isolation of DNA from mammalian cells. In: Nolan C, ed. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989:9.16-9.19.
20. Lehman TC, Hale DE, Bhala A, Thorpe C. An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. Anal Biochem. 1990;186:280-284.
21. Djouadi F, Bastin J, Kelly DP, Merlet-Benichou C. Transcriptional regulation of mitochondrial oxidative enzyme genes in the developing rat kidney by glucocorticoids. Biochem J. 1996;315:555-562.
22. Schwartz K, Boheler K, de la Bastie D, Lompre AM, Mercadier JJ. Swilches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol. 1992;262:R364-R369.
23. Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res. 1990;18:6927-6933.
24. Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension. 1988;11:416-426.
25. Alpert NR, Mulieri LA. Increased myothermal economy of isometric force generation in compensated cardiac hypertrophy induced by pulmonary artery constriction in me rabbit: a characterization of heat liberation on normal and hypertrophied right ventricular papillary muscles. Circ Res. 1982;50:491-500.
26. Christe ME, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol. 1994;26:1371-1375.
27. Takeyama D, Kagaya Y, Yamane Y, Shiba N, Chida M, Takahashi T, Ido T, Ishide N, Takishima T. Effects of chronic right ventricular pressure overload on myocardial glucose and free fatty acid metabolism in the conscious rat. Cardiovasc Res. 1995;29:763-767.
28. Massie BM, Schaefer S, Garcia J, McKirnan D, Schwartz GG, Wisneski JA, Weiner MW, White FC. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation. 1995;91:1814-1823.
29. Alpert NR, Gordon MS. Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol. 1962;202:940-946.
30. Lompré AM, Schwartz K, Albis A, Lacombe B, Thiem NV, Swynghedauw B. Myosin isozymes redistribution in chronic heart overloading. Nature. 1979;282:105-107.
31. Nadal-Ginard B, Mahdavi V. Molecular basis of cardiac performance: plasticity of the myocardium generated through protein isoform switches. J Clin Invest. 1989;84:1694-1700.
32. 2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci U S A. 1989;86:2966-2970.
33. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 1990;85:305-309.
34. 2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res. 1990;66:554-564.
35. Arai M, Alpert NR, MacLennan DH, Barton P. Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 1993;72:463-469.
36. Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184-192.
37. Izumo S, Lompré AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B, Mahdavi V. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy: interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest. 1987;79:970-977.
38. +)-ATPase activity in rat cardiac hypertrophy: expression of the neonatal forms. J Biol Chem. 1986;261:185-189.
39. Nagao M, Parimoo B, Tanaka K. Developmental, nutritional, and hormonal regulation of tissue-specific expression of the genes encoding various acyl-CoA dehydrogenases and α-subunit of electron transfer flavoprotein in rat. J Biol Chem. 1993;268:24114-24124.
40. Carroll JE, McGuire BS, Chancey VF, Harrison KB. Acyl-CoA dehydrogenase enzymes during early postnatal development in the rat. Biol Neonate. 1989;55:185-190.
41. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest. 1989;83:927-936.
42. Schaper J, Froede R, St Hein TA, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991;83:504-514.